34 results on '"Mutafoglu K"'
Search Results
2. wpn2030 - Wissenschaftsplattform Nachhaltigkeit 2030. Kommunen befähigen, stärken und in den Mittelpunkt rücken. Impuls zum Staatssekretärsausschuss für nachhaltige Entwicklung 'Kommunen als zentrale Akteure für eine nachhaltige Entwicklung' am 15.02.2021
3. wpn2030 - Wissenschaftsplattform Nachhaltigkeit 2030. Wissenschaftliche Impulse zur Stärkung einer Global-Commons-Politik. Abschlussbericht der wpn2030-Arbeitsgruppe 'Global Commons'
4. wpn2030 - Wissenschaftsplattform Nachhaltigkeit 2030. Wege zu einer nachhaltigen Arbeitswelt. Abschlussbericht der wpn2030-Arbeitsgruppe ‚Zukunft der Arbeit‘
5. Dokuz Eylul University Pediatric Oncology Group: Ewing Sarcoma Family of Tumors Experience
6. Localized Neuroblastoma: The 30 Years Experience of Dokuz Eylul University
7. Treatment of Neuroblastoma in Infants Younger than 18 Months: The 30 Years Experience of Dokuz Eylul University
8. Evaluation of Ototoxicity in Children with Head and Neck Cancer who Received Cisplatin and/or Carboplatin During Treatment
9. Treatment of Children with Intermediate-Risk Neuroblastoma: Dokuz Eylul University Experience
10. Dokuz Eylul University Treatment Experience of Neuroblastoma
11. Treatment Results in Pediatric Head and Neck Rhabdomyosarcomas: A Single Center Experience
12. Head and Neck Hemangiomas of Childhood: A Single Center Experience
13. Paediatric Hodgkin lymphoma A single center experience from the West Part of Turkey
14. Prospective, Observational Nationwide Study on Pharmacogenomics/Genetics of Childhood Cancers in a Cohort of Turkish Paediatric Oncology Group (TURKPEDPGX)
15. Reconciling development and conservation under coastal squeeze from rising sea level
16. TREATMENT RESULTS OF PEDIATRIC GERM CELL TUMORS FROM A SINGLE INSTITUTION
17. THE CURRENT STATUS OF FOLLOW-UP SERVICES FOR CHILDHOOD CANCER SURVIVORS IN TURKISH PEDIATRIC ONCOLOGY CENTERS
18. LANGERHANS CELL HISTIOCYTOSIS: A SINGLE CENTER EXPERIENCE
19. EVALUATION OF OTOTOXICITY IN CHILDREN WITH CANCER WHO RECEIVED CISPLATIN AND/OR CARBOPLATIN DURING TREATMENT
20. CLINICAL SIGNIFICANCE OF DNA REPAIR GENES EXPRESSIONS IN NEUROFIBROMATOSIS TYPE 1 CASES
21. Evaluation of Musculoskeletal Complaints and Skeletal Involvements in Children with Newly Diagnosed Lymphoma and Solid Tumors
22. POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: EXPERIENCE OF THREE PATIENTS
23. HEPATOBLASTOMA: CLINICAL CHARACTERISTICS AND OUTCOME OF 13 PATIENTS
24. A Single Center Experience of a Treatment for Medulloblastoma
25. A single center experience of pediatric Hodgkin lymphoma
26. Langerhans Cell Histiocytosis: A Single Center Experience
27. CHILDREN WITH RET PROTOONCOGENE CODON 634 MUTATION
28. RHABDOMYOSARCOMA EXPERIENCE: A SINGLE INSTITUTION'S RESULTS
29. Retrospective Analysis of Our Patients with Pons Glioma
30. Treatment of Relapse Neuroblastoma: Dokuz Eylul University Experience
31. Treatment of Stage 4S Neuroblastoma: Dokuz Eylul University Experience of the Last 10 Years
32. Could the Unidentified Bright Objects in Children be Accepted as an Additional Diagnostic Criterion for Neurofibromatosis Type-1?
33. ACETYL-L-CARNITINE HAS PROTECTIVE EFFECTS AGAINST EXPERIMENTAL DOXORUBICIN CARDIOTOXICITY
34. wpn2030 - Wissenschaftsplattform Nachhaltigkeit 2030. Finding a sustainable pathway out of the coronavirus crisis. Recommendations from the Science Platform Sustainability 2030 to strengthen Germany's Sustainable Development Policy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.